Drreddys Laboratories | RDY - 净收入

金融业

INR

INR 6.26B

现金及等价物

INR 18.66B

INR 40.46B

INR 3.31B

INR 1.76B

INR 67.73B

股息收益率

INR 0.65

INR 16.37B

INR 21.59B

INR 27.81K

EPS每股收益

INR 0.16

股本和储备

INR 4.14B

INR 46.81B

债务利息支出

INR 944M

INR 796M

INR 129.19M

INR 2.19B

INR 12.1B

INR 72.94B

INR 14.33B

普通股股本

INR 832.57M

18.27

INR 15.43B

INR 87.27B

销售和管理费用

INR 26.92B

INR 79.01B

贸易债权人

INR 454.04M

应收帐款人

INR 1.41B

	净收入	更改		日
ANI Pharmaceuticals	USD 32.35M		6.08M	2025-12
Aurora Cannabis	CAD 1.82M		53.29M	2025-12
Bayer	EUR -3.76B		2.79B	2025-12
Canopy Growth	CAD -62.63M		60.99M	2025-12
Cipla	INR 6.76B		6.75B	2025-12
Corcept Therapeutics	USD 24.29M		4.62M	2025-12
Drreddys Laboratories	INR 12.1B		2.08B	2025-12
GlaxoSmithKline	GBP 636M		1.38B	2025-12
Hikma Pharmaceutical	USD 164M		45M	2025-12
Lonza	CHF 426M		119M	2025-06
Novartis	USD 2.41B		1.52B	2025-12
Pacira	USD 1.64M		3.8M	2025-12
Phibro Animal Health	USD 27.46M		932K	2025-12
Prestige Brands	USD 46.7M		22.44M	2025-12
Richter Gedeon	HUF 43.35B		8.49B	2025-09
Sun Pharmaceuticals	INR 33.69B		2.51B	2025-12
Supernus Pharmaceuticals	USD -45.12M		67.62M	2025-09
Teva Pharmaceutical Industries	USD 480M		47M	2025-12